These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 4455367)
21. [Pharmacogenetics, its achievements and perspectives (review of the literature)]. Skakun NP Vrach Delo; 1974 Mar; (3):1-4. PubMed ID: 4619733 [No Abstract] [Full Text] [Related]
22. Genetic factors in hepatic drug oxidation. Kalow W; Inaba T Prog Liver Dis; 1976; 5():246-58. PubMed ID: 775542 [No Abstract] [Full Text] [Related]
23. [Significance of biotransformation for the elimination of drugs. Peculiarities in childhood, in liver diseases and after enzyme induction]. Klinger W Pharm Prax; 1968; 5():100-3. PubMed ID: 5713889 [No Abstract] [Full Text] [Related]
25. Nutrient and non-nutrient effects on drug metabolism. Hathcock JN Drug Nutr Interact; 1985; 4(1-2):217-34. PubMed ID: 3908043 [No Abstract] [Full Text] [Related]
26. Biotransformation of drugs during aging. Kiechel JR Gerontology; 1982; 28 Suppl 1():101-12. PubMed ID: 7044902 [TBL] [Abstract][Full Text] [Related]
27. The effect of spironolactone on drug metabolism by hepatic microsomes. Stripp B; Hamrick ME; Zampaglione NG; Gillette JR J Pharmacol Exp Ther; 1971 Mar; 176(3):766-71. PubMed ID: 5111461 [No Abstract] [Full Text] [Related]
28. Adaptive responses of the liver to foreign compounds, with special reference to microsomal drug-matabolizing enzymes. Wada O; Yano Y Rev Environ Health; 1974; 1(4):261-82. PubMed ID: 4617260 [No Abstract] [Full Text] [Related]
29. Factors affecting drug metabolism. Gillette JR Ann N Y Acad Sci; 1971 Jul; 179():43-66. PubMed ID: 4398309 [No Abstract] [Full Text] [Related]
30. The skin as a drug-metabolizing organ. Pannatier A; Jenner P; Testa B; Etter JC Drug Metab Rev; 1978; 8(2):319-43. PubMed ID: 363387 [No Abstract] [Full Text] [Related]
31. Effect of enzyme induction on the metabolism of benzo(a)pyrene and 3'-methyl-4-monomethylaminoazobenzene in the pregnant and fetal rat. Welch RM; Gommi B; Alvares AP; Conney AH Cancer Res; 1972 May; 32(5):973-8. PubMed ID: 5017744 [No Abstract] [Full Text] [Related]
32. [Role of monoxygenases in the metabolism of drugs in the human fetus and newborn infant]. Cresteil T; Leroux JP Arch Fr Pediatr; 1982; 39(7):463-70. PubMed ID: 6816186 [TBL] [Abstract][Full Text] [Related]
33. [Genetic significance of determined oxidation of drugs and xenobiotics in the pathogenesis of neoplastic diseases]. Niewiński P; Orzechowska-Juzwenko K Pol Merkur Lekarski; 1997 Jan; 2(7):71-5. PubMed ID: 9296908 [No Abstract] [Full Text] [Related]
34. Drugs and the ageing liver. James OF J Hepatol; 1985; 1(4):431-5. PubMed ID: 3902953 [No Abstract] [Full Text] [Related]
35. [The role of genetically determined oxidation of drugs and xenobiotics in pathogenesis of neoplastic diseases]. Niewiński P; Orzechowska-Juzwenko K Postepy Hig Med Dosw; 1996; 50(4):321-32. PubMed ID: 9019742 [TBL] [Abstract][Full Text] [Related]
36. Molybdenum hydroxylases as drug-metabolizing enzymes. Beedham C Drug Metab Rev; 1985; 16(1-2):119-56. PubMed ID: 3905316 [No Abstract] [Full Text] [Related]
38. The influence of host factors on drug response. VI. Hepatocellular diseases. Vesell ES Ration Drug Ther; 1981 Aug; 15(8):1-8. PubMed ID: 7347855 [No Abstract] [Full Text] [Related]
40. Endogenous growth hormone and the regulation of hepatic drug oxidation in the male rat. Virgo BB Prog Clin Biol Res; 1983; 135():379-82. PubMed ID: 6141572 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]